PharmaCyte Biotech Inc (PMCB)
2.09
-0.03
(-1.42%)
USD |
NASDAQ |
Apr 26, 13:50
PharmaCyte Biotech Total Assets (Quarterly): 71.36M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 71.36M |
| October 31, 2023 | 78.88M |
| July 31, 2023 | 79.88M |
| April 30, 2023 | 73.28M |
| January 31, 2023 | 77.95M |
| October 31, 2022 | 82.35M |
| July 31, 2022 | 87.39M |
| April 30, 2022 | 90.62M |
| January 31, 2022 | 91.94M |
| October 31, 2021 | 92.31M |
| July 31, 2021 | 6.637M |
| April 30, 2021 | 7.404M |
| January 31, 2021 | 8.262M |
| October 31, 2020 | 8.941M |
| July 31, 2020 | 7.432M |
| April 30, 2020 | 6.167M |
| January 31, 2020 | 5.338M |
| October 31, 2019 | 5.338M |
| July 31, 2019 | 5.606M |
| April 30, 2019 | 5.782M |
| January 31, 2019 | 5.837M |
| October 31, 2018 | 6.067M |
| July 31, 2018 | 7.081M |
| April 30, 2018 | 6.413M |
| January 31, 2018 | 6.725M |
| Date | Value |
|---|---|
| October 31, 2017 | 7.915M |
| July 31, 2017 | 9.525M |
| April 30, 2017 | 8.668M |
| January 31, 2017 | 7.615M |
| October 31, 2016 | 6.732M |
| July 31, 2016 | 7.524M |
| April 30, 2016 | 7.160M |
| January 31, 2016 | 8.002M |
| October 31, 2015 | 7.642M |
| July 31, 2015 | 8.143M |
| April 30, 2015 | 9.298M |
| January 31, 2015 | 6.626M |
| October 31, 2014 | 6.659M |
| July 31, 2014 | 8.198M |
| April 30, 2014 | 9.316M |
| January 31, 2014 | 5.662M |
| October 31, 2013 | 4.594M |
| July 31, 2013 | 3.394M |
| April 30, 2013 | 2.877M |
| January 31, 2013 | 2.451M |
| October 31, 2012 | 2.316M |
| July 31, 2012 | 2.234M |
| April 30, 2012 | 2.088M |
| January 31, 2012 | 1.864M |
| October 31, 2011 | 1.726M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.338M
Minimum
Jan 2020
92.31M
Maximum
Oct 2021
44.64M
Average
40.15M
Median
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 28.71M |
| AIM ImmunoTech Inc | 19.38M |
| IGC Pharma Inc | 11.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Protalix BioTherapeutics Inc | 84.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 22.47M |
| Shareholders Equity (Quarterly) | 48.89M |